| Gray matter atrophy in multiple sclerosis: a longitudinal study E Fisher, JC Lee, K Nakamura, RA Rudick Annals of neurology 64 (3), 255-265, 2008 | 839 | 2008 |
| Phase 2 trial of ibudilast in progressive multiple sclerosis RJ Fox, CS Coffey, R Conwit, ME Cudkowicz, T Gleason, A Goodman, ... New England Journal of Medicine 379 (9), 846-855, 2018 | 299 | 2018 |
| Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial RR Voskuhl, HJ Wang, TCJ Wu, NL Sicotte, K Nakamura, F Kurth, N Itoh, ... The Lancet Neurology 15 (1), 35-46, 2016 | 231 | 2016 |
| Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS RA Rudick, JC Lee, K Nakamura, E Fisher Journal of the neurological sciences 282 (1-2), 106-111, 2009 | 176 | 2009 |
| Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study BD Trapp, M Vignos, J Dudman, A Chang, E Fisher, SM Staugaitis, ... The Lancet Neurology 17 (10), 870-884, 2018 | 166 | 2018 |
| Imaging correlates of axonal swelling in chronic multiple sclerosis brains E Fisher, A Chang, RJ Fox, JA Tkach, T Svarovsky, K Nakamura, ... Annals of neurology 62 (3), 219-228, 2007 | 148 | 2007 |
| Diurnal fluctuations in brain volume: statistical analyses of MRI from large populations K Nakamura, RA Brown, S Narayanan, DL Collins, DL Arnold, ... Neuroimage 118, 126-132, 2015 | 131 | 2015 |
| Automated cartilage and meniscus segmentation of knee MRI with conditional generative adversarial networks S Gaj, M Yang, K Nakamura, X Li Magnetic resonance in medicine 84 (1), 437-449, 2020 | 119 | 2020 |
| Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients K Nakamura, E Fisher Neuroimage 44 (3), 769-776, 2009 | 118 | 2009 |
| Clinically feasible MTR is sensitive to cortical demyelination in MS JTH Chen, K Easley, C Schneider, K Nakamura, GJ Kidd, A Chang, ... Neurology 80 (3), 246-252, 2013 | 110 | 2013 |
| T1‐/T2‐weighted ratio differs in demyelinated cortex in multiple sclerosis K Nakamura, JT Chen, D Ontaneda, RJ Fox, BD Trapp Annals of neurology 82 (4), 635-639, 2017 | 109 | 2017 |
| Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: implications for monitoring atrophy in clinical studies K Nakamura, RA Brown, D Araujo, S Narayanan, DL Arnold NeuroImage: Clinical 6, 166-170, 2014 | 100 | 2014 |
| Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis K Nakamura, N Guizard, VS Fonov, S Narayanan, DL Collins, DL Arnold NeuroImage Clinical 4, 10-17, 2014 | 99 | 2014 |
| The international workshop on osteoarthritis imaging knee MRI segmentation challenge: a multi-institute evaluation and analysis framework on a standardized dataset AD Desai, F Caliva, C Iriondo, A Mortazi, S Jambawalikar, U Bagci, ... Radiology: Artificial Intelligence 3 (3), e200078, 2021 | 66 | 2021 |
| CLADA: cortical longitudinal atrophy detection algorithm K Nakamura, R Fox, E Fisher Neuroimage 54 (1), 278-289, 2011 | 63 | 2011 |
| Estimating and accounting for the effect of MRI scanner changes on longitudinal whole-brain volume change measurements H Lee, K Nakamura, S Narayanan, RA Brown, DL Arnold, ... Neuroimage 184, 555-565, 2019 | 56 | 2019 |
| Intrinsic and extrinsic mechanisms of thalamic pathology in multiple sclerosis KR Mahajan, K Nakamura, JA Cohen, BD Trapp, D Ontaneda Annals of neurology 88 (1), 81-92, 2020 | 54 | 2020 |
| Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: the DELIVER-MS study protocol D Ontaneda, EC Tallantyre, PC Raza, SM Planchon, K Nakamura, ... Contemporary Clinical Trials 95, 106009, 2020 | 53 | 2020 |
| Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial AJ Coles, DL Arnold, AD Bass, AL Boster, DAS Compston, Ó Fernández, ... Therapeutic Advances in Neurological Disorders 14, 1756286420982134, 2021 | 49 | 2021 |
| Multi-vendor multi-site T1ρ and T2 quantification of knee cartilage J Kim, K Mamoto, R Lartey, K Xu, K Nakamura, W Shin, CS Winalski, ... Osteoarthritis and cartilage 28 (12), 1539-1550, 2020 | 45 | 2020 |
Daniel Ontaneda, MD PhDCleveland Clinic Foundation, Professor of NeurologyBestätigte E-Mail-Adresse bei ccf.org
